Bond Screener
Sandoz Group
LEI 5493000JWK6XWFEUD320
Organization name
Sandoz Group AG
Country name
Switzerland
Country of registration
Switzerland
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
5,709 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Sandoz Group AG operates as a pharmaceutical company. The Company manufactures and distributes generic and biosimilar medicines for the treatment of patients with diseases such as cancer, diabetes, and arthritis. Sandoz Group serves customers worldwide.
|
General information
-
Organization nameSandoz Group AG
-
Organization statusOperating organization
-
AddressSUURSTOFFI 14, ROTKREUZ, Switzerland, 6343
-
Site
-
IR Site
News
-
New issues: Sandoz Group issued bonds (CH1543592732, CH1543592740) in the amount of CHF 275, CHF 275 mln maturing in 2032, 2036 respectively.14/03/2026
-
New issue: Sandoz Group issued international bonds (XS3032013511) with the coupon rate of 4% in the amount of EUR 500 mln maturing in 203518/03/2025
-
New issue: Sandoz Group issued international bonds (XS2900391777) with the coupon rate of 3.25% in the amount of EUR 600 mln maturing in 202909/09/2024
-
New issue: Issuer Sandoz Group issued international bonds (XS2715297672) with the coupon rate of 3.97% in the amount of EUR 700 mln maturing in 202710/11/2023
-
New issues: Issuer Sandoz Group released international bonds (XS2715941949, XS2715940891) in the amount of EUR 600, EUR 700 mln maturing in 2033, 2030 respectively.09/11/2023
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
Show more
Hide
Authorization required
You need to request access
